Watson Laboratories, Inc.

24 articles about Watson Laboratories, Inc.

• Miller Law LLC, Hilliard & Shadowen LLP, Motley Rice LLC, and Cohen Milstein Sellers & Toll PLLC Announce Notice of Class Action for In re Loestrin 24 Fe Antitrust Litigation

  10/1/2019

  If You Purchased Loestrin 24 Fe, Minastrin 24 Fe and/or Their Generic Equivalent(s) a Class Action Lawsuit May Affect Your Rights

• United Therapeutics Announces Settlement Of Patent Litigation With Watson Laboratories, Inc. Relating To Tyvaso

  8/9/2018

  United Therapeutics Corporation announced today that it has entered into a Settlement Agreement with Watson Laboratories, Inc.

• Tenax Therapeutics Announces Appointment of Anthony A. DiTonno as CEO

  6/5/2018

  Tenax Therapeutics, Inc. today announced the Company has selected board member Anthony A. DiTonno to be its next Chief Executive Officer, effective June 1, 2018.

• Allergan's Watson Laboratories Opts to Terminate Epinephrine PFS Agreement With Adamis

  7/21/2016

• Horizon Pharma plc. Files Patent Infringement Lawsuit Against Watson Laboratories, Inc. For Filing An ANDA Against PENNSAID(R) 2%

  12/29/2014

• Horizon Pharma, Inc. Files Patent Infringement Lawsuit Against Watson Laboratories, Inc. - Florida for Filing an ANDA Against RAYOS®

  8/28/2013

• Supernus Pharmaceuticals Sues Watson Laboratories, Inc. for Infringement of Oxtellar XR™ Patents

  8/8/2013

• Watson Laboratories, Inc. Recalls Two Lots of Hydrocodone Pain Drug

  9/24/2012

• Watson Laboratories, Inc.'s Gets Approval for Generic Rheumatoid Arthritis Drug

  7/12/2012

• Hi-Tech Pharmacal Acquires Cormax Brand Rights from Watson Laboratories, Inc. for Undisclosed Amount

  6/4/2012

• Auxilium Pharmaceuticals and FCB I LLC File Lawsuit Against Watson Laboratories, Inc. for Infringement of Testim® Patents

  5/24/2012

• Auxilium Pharmaceuticals and FCB I LLC Receive Paragraph IV Certification Notice from Watson Laboratories, Inc. for Testim(R)

  4/17/2012

• Columbia Laboratories, Inc. and Watson Laboratories, Inc. Confirm FDA Advisory Committee to Review Preterm Birth NDA

  11/10/2011

• Watson Laboratories, Inc. and Andrx Corporation Confirms OxyContin(R) Patent Challenge; Filed ANDA

  3/28/2011

• Ortho-McNeil Pharmaceutical, Inc. Enters into Agreement with Watson Laboratories, Inc. for CONCERTA(R) Authorized Generic

  11/2/2010

• Watson Laboratories, Inc. Confirms Combigan(R) Patent Challenge From Allergan Inc.

  9/7/2010

• IMPAX Laboratories, Inc. Acquires Rights to Abbreviated New Drug Applications From Watson Laboratories, Inc. And Cobalt Laboratories

  12/2/2009

• Warner Chilcott Files Lawsuit Against Watson Laboratories, Inc. for Infringement of FEMCON FE Patent

  10/1/2007

• Merck & Co., Inc., Abbott Laboratories, Watson Laboratories, Inc. And Many More To Present At The 5th Contract Manufacturing For Pharmaceuticals Conference

  10/16/2006

• Warner Chilcott Sues Watson Laboratories, Inc. For Infringement Of Loestrin(R) 24 Fe Patent

  8/1/2006